ATE308551T1 - Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten - Google Patents

Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten

Info

Publication number
ATE308551T1
ATE308551T1 AT00956040T AT00956040T ATE308551T1 AT E308551 T1 ATE308551 T1 AT E308551T1 AT 00956040 T AT00956040 T AT 00956040T AT 00956040 T AT00956040 T AT 00956040T AT E308551 T1 ATE308551 T1 AT E308551T1
Authority
AT
Austria
Prior art keywords
oligosaccharides
ribtol
ribose
phosphate
vaccines containing
Prior art date
Application number
AT00956040T
Other languages
English (en)
Inventor
Bencomo Vicente Guillerm Verez
Centro Habana Peregrino
Rene Roy
Original Assignee
Univ La Habana
Univ Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ La Habana, Univ Ottawa filed Critical Univ La Habana
Application granted granted Critical
Publication of ATE308551T1 publication Critical patent/ATE308551T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08—Polyoxyalkylene derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT00956040T 1999-08-30 2000-08-15 Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten ATE308551T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1999121A CU22904A1 (es) 1999-08-30 1999-08-30 Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
PCT/CU2000/000003 WO2001016146A1 (es) 1999-08-30 2000-08-15 Oligosacáridos derivados de ribosa-ribitol-fosfato y vacunas que los contienen

Publications (1)

Publication Number Publication Date
ATE308551T1 true ATE308551T1 (de) 2005-11-15

Family

ID=5459405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956040T ATE308551T1 (de) 1999-08-30 2000-08-15 Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten

Country Status (23)

Country Link
US (1) US6765091B1 (de)
EP (1) EP1212334B1 (de)
JP (1) JP4850377B2 (de)
KR (1) KR100818163B1 (de)
CN (1) CN1205217C (de)
AR (1) AR025435A1 (de)
AT (1) ATE308551T1 (de)
AU (1) AU780816B2 (de)
BR (1) BRPI0013686B8 (de)
CA (1) CA2382602C (de)
CO (1) CO5180646A1 (de)
CU (1) CU22904A1 (de)
CZ (1) CZ2002721A3 (de)
DE (1) DE60023722T2 (de)
DK (1) DK1212334T3 (de)
EA (1) EA005381B1 (de)
ES (1) ES2252045T3 (de)
MX (1) MXPA02002066A (de)
NZ (1) NZ517464A (de)
SI (1) SI1212334T1 (de)
UA (1) UA75579C2 (de)
WO (1) WO2001016146A1 (de)
ZA (1) ZA200201667B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2556169C (en) * 2004-01-29 2011-11-22 Andrew Lees Use of amino-oxy functional groups in the preparation of vaccines
WO2011017101A2 (en) 2009-07-27 2011-02-10 Fina Biosolutions, Llc Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
WO2011011879A1 (en) 2009-07-31 2011-02-03 National Research Council Of Canada H. pylori lipopolysaccharide outer core epitope
CA2836153C (en) 2009-12-17 2016-06-21 Fina Biosolutions, Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
EP2560738B8 (de) * 2010-04-23 2019-09-25 Serum Institute of India Private Limited Einfaches verfahren zur simultanen beseitigung mehrerer unreinheiten aus kulturüberständen auf extrem geringe konzentrationen
KR102549847B1 (ko) 2016-07-28 2023-06-29 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. 헤모필루스 인플루엔자 타입 b에 대항하는 백신으로서 안정한 가수분해-내성 합성 폴리리보실리비톨포스페이트 유도체
WO2019178699A1 (en) * 2018-03-23 2019-09-26 Koranex Capital Precision glycoconjugates as therapeutic tools

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
EP0320942A3 (de) * 1987-12-18 1989-10-04 American Cyanamid Company Polysaccharide und makromolekulare Verbindungen davon
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae

Also Published As

Publication number Publication date
BRPI0013686B1 (pt) 2016-07-26
EP1212334B1 (de) 2005-11-02
JP2003528032A (ja) 2003-09-24
BR0013686A (pt) 2002-08-13
SI1212334T1 (sl) 2006-04-30
KR20020068501A (ko) 2002-08-27
UA75579C2 (en) 2006-05-15
AR025435A1 (es) 2002-11-27
WO2001016146A1 (es) 2001-03-08
NZ517464A (en) 2004-03-26
CU22904A1 (es) 2004-01-23
EA005381B1 (ru) 2005-02-24
AU6817300A (en) 2001-03-26
AU780816B2 (en) 2005-04-21
DK1212334T3 (da) 2006-03-20
EA200200314A1 (ru) 2002-10-31
DE60023722D1 (de) 2005-12-08
CO5180646A1 (es) 2002-07-30
CN1205217C (zh) 2005-06-08
BRPI0013686B8 (pt) 2021-05-25
CN1376158A (zh) 2002-10-23
CA2382602C (en) 2010-02-16
JP4850377B2 (ja) 2012-01-11
HK1050693A1 (en) 2003-07-04
KR100818163B1 (ko) 2008-03-31
ES2252045T3 (es) 2006-05-16
CZ2002721A3 (cs) 2002-07-17
ZA200201667B (en) 2003-08-27
MXPA02002066A (es) 2004-07-30
US6765091B1 (en) 2004-07-20
DE60023722T2 (de) 2006-07-20
EP1212334A1 (de) 2002-06-12
CA2382602A1 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
DE60122193D1 (de) Glucopyranosyloxybenzylbenzol derivate und medizinische zusammensetzungen, die diese verbindungen enthalten
PT956858E (pt) Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
NO20010808D0 (no) Kjeveortopedisk innretning for fremskyving av underkjeven
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
EE200100179A (et) Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
DE69916586D1 (de) Indol-derivate und medizinische zusammensetzungen die diese enthalten
DE69912449D1 (de) Schweisshemmende mittel und zusammensetzungen die diese enthalten
FR2773804B1 (fr) Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
ATE308551T1 (de) Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten
DE69529090D1 (de) Polymerisierbare verbindungen und zusammensetzungen
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
FR2791980B1 (fr) Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
DE69931038D1 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
ID29219A (id) (1-fenasi-3-fenil-3-piperidiletil): turunan-turunan piperidin, proses untuk memperolehnya dan komposisi-komposisi farmasi
ZA200006732B (en) Utilization of Aryl (or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation.
MXPA01011296A (es) Composiciones contraceptivas que contienen derivados de indolina y agentes progestacionales.
DZ3039A1 (fr) Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae.
DE60011060D1 (de) Virus behandlung
HUP0001891A2 (en) Medicament for the treatment of migraine
IT1310896B1 (it) Articolatore per odontotecnica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1212334

Country of ref document: EP